| Followers | 401 |
| Posts | 10673 |
| Boards Moderated | 1 |
| Alias Born | 04/20/2014 |
Thursday, April 14, 2016 7:49:08 AM
If it will make another strong move..it will do it with short little candles...any quick movement up..would suggest short lived energy aka Great SHORT opportunity...any gradual movement down with small candles would suggest "short trap" most likely will do another intra day spike, possibly 50% or more....
Any gradual move up.....would indicate strong bullish move once again.
On a chart like RPRX i would stay FAR FAR FAR away from shorting. Give it 3 days before CONSIDERING shorting.
Focus on making money here long
The float isn't exactly that tiny. But with that given factor , it still can prove to move nicely.
Also notice HEDGE FUNDS HEAVY interest in it. something like 60% or so i believe .
When HEDGE FUNDS own that much of a stock,,,its a good thing and bad...the BAD PART: is if they feel like , any moment , they can let go of half or 1/3 or full position at open market, creating a DUMPAGE situation. Or they can hold... point is...this can drop fast and without warning....something to keep in mind.
Any gradual move up.....would indicate strong bullish move once again.
On a chart like RPRX i would stay FAR FAR FAR away from shorting. Give it 3 days before CONSIDERING shorting.
Focus on making money here long
The float isn't exactly that tiny. But with that given factor , it still can prove to move nicely.
Also notice HEDGE FUNDS HEAVY interest in it. something like 60% or so i believe .
When HEDGE FUNDS own that much of a stock,,,its a good thing and bad...the BAD PART: is if they feel like , any moment , they can let go of half or 1/3 or full position at open market, creating a DUMPAGE situation. Or they can hold... point is...this can drop fast and without warning....something to keep in mind.
Recent RPRX News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/20/2026 08:23:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:38:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2026 09:22:49 PM
- Form 13F-NT - Quarterly report filed by institutional managers, Notice • Edgar (US Regulatory) • 05/14/2026 06:29:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:14:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:12:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:10:50 PM
- Royalty Pharma to present at upcoming investor conferences • GlobeNewswire Inc. • 05/07/2026 08:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 01:04:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:31:54 AM
- Royalty Pharma reports first quarter 2026 results • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/30/2026 09:54:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/28/2026 09:00:16 PM
- Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation • GlobeNewswire Inc. • 04/21/2026 05:00:00 PM
- Royalty Pharma Declares Second Quarter 2026 Dividend • GlobeNewswire Inc. • 04/17/2026 12:30:00 PM
- Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 • GlobeNewswire Inc. • 04/15/2026 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 01:53:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/10/2026 08:11:03 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 08:10:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:58:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/01/2026 08:55:58 PM
- Royalty Pharma signs $500M co-development agreement with J&J • IH Market News • 03/30/2026 12:28:19 PM
- Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases • GlobeNewswire Inc. • 03/30/2026 11:15:00 AM

